Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Radiat Prot Dosimetry ; 120(1-4): 95-9, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16644958

RESUMO

A thermoluminescence dosimetry (TLD) system was characterised at SSDL-ININ to verify the air-kerma strength (S(K)) and dose-to-water (D(W)) values for (137)Cs sources used in low dose rate (LDR) brachytherapy treatments at the Hospital General de Mexico (HGM). It consists of a Harshaw 3500 reader and a set of TLD-100 powder capsules. The samples of TLD-100 powder were calibrated in terms of D(W) vs. nC or nC mg(-1), and their dose response curves were corrected for supralinearity. The D(W) was calculated using the AAPM TG-43 formalism using S(K) for a CDCSM4 (137)Cs reference source. The S(K) value was obtained by using a NE 2611 chamber, and with two well chambers. The angular anisotropy factor was measured with the NE 2611 chamber for this source. The HGM irradiated TLD-100 powder capsules to a reference dose D(W) of 2 Gy with their (137)Cs sources. The percent deviations between the imparted and reference doses were 1.2% < or = Delta < or = 6.5%, which are consistent with the combined uncertainties: 5.6% < or = u(c) < or = 9.8% for D(W).


Assuntos
Braquiterapia/normas , Radioisótopos de Césio/análise , Radioisótopos de Césio/uso terapêutico , Dosimetria Termoluminescente/métodos , Dosimetria Termoluminescente/normas , Água , Carga Corporal (Radioterapia) , Braquiterapia/métodos , México , Dosagem Radioterapêutica , Valores de Referência , Eficiência Biológica Relativa
2.
Arch Inst Cardiol Mex ; 54(5): 431-40, 1984.
Artigo em Espanhol | MEDLINE | ID: mdl-6517640

RESUMO

It has been reported recently that 5-amino-34,4'-bipyridine-6(1H)-one is a new positive inotropic agent that appears to offer significant advantages over the cardiac glycosides. The effects of this agent were studied in a modified heart-lung preparation which allows the measurement of coronary flow and oxygen consumption in addition to a controlled study of cardiac contractility. In two models of cardiac insufficiency the administration of 5 mg amrinone caused a marked increase in cardiac output and a considerable decrease in left atrial pressure with complete reversal of the failure. In addition, the drug produces a 78% increase in coronary flow. Amrinone produces in these preparations a proportionally larger increase in cardiac output than in oxygen consumption, thus this agent increases cardiac efficiency. These results suggest that this new compound could be very useful in the treatment of cardiac insufficiency in congestive heart failure.


Assuntos
Aminopiridinas/farmacologia , Cardiotônicos/farmacologia , Circulação Coronária/efeitos dos fármacos , Hemodinâmica/efeitos dos fármacos , Amrinona , Animais , Cães , Feminino , Coração/efeitos dos fármacos , Insuficiência Cardíaca/fisiopatologia , Testes de Função Cardíaca , Masculino , Miocárdio/metabolismo , Consumo de Oxigênio/efeitos dos fármacos
4.
Arch Inst Cardiol Mex ; 51(6): 511-9, 1981.
Artigo em Espanhol | MEDLINE | ID: mdl-7325742

RESUMO

THe synergistic effects between calcium and the therapeutic and toxic actions of the cardiac glycosides have suggested that a way of treating digitalis intoxication could be through a decrease in free plasma calcium. In 1966, Burckhardt and La-Due published a study based on the inverse relationship that exists between plasma phosphates and calcium. It was shown then that potassium phosphate had a pronounced antiarrhythmic effect on digitalis induced arrhythmias. The use of potassium phosphate for this study prevented the analysis of the role of the phosphates in these effects, since the actions of potassium in digitalis toxicity precluded any conclusion. The purpose of the present paper is to study the effect of phosphates on digitalis intoxication and its possible mechanism of action. The results obtained demonstrated: 1) Phosphates have a marked antiarrhythmic effect in digitalis induced arrhythmias. 2) This effect is due to a decrease in free plasma calcium. 3) The lowering of this calcium pool occurs in the blood and is not mediated by hormonal or renal mechanisms. 4) The ions that disappear from the free calcium pool do not precipitate. 5) The use of phosphates could be useful in the treatment of some clinical cases of advanced digitalis intoxication.


Assuntos
Antiarrítmicos/uso terapêutico , Glicosídeos Digitálicos/intoxicação , Fosfatos/uso terapêutico , Animais , Arritmias Cardíacas/tratamento farmacológico , Fosfatos de Cálcio/uso terapêutico , Cães , Avaliação Pré-Clínica de Medicamentos , Sinergismo Farmacológico , Feminino , Técnicas In Vitro , Masculino , Potenciais da Membrana/efeitos dos fármacos , Fósforo/uso terapêutico , Sódio/uso terapêutico
5.
Arch Inst Cardiol Mex ; 51(6): 521-8, 1981.
Artigo em Espanhol | MEDLINE | ID: mdl-7325743

RESUMO

The preceding paper (published in the issue) demonstrated that the administration of sodium phosphates exerted a marked antiarrhythmic effect on several models of digitalis intoxication; this action being due to a decrease in the free calcium fraction. THe purpose of the present paper is to analyze the effects that several concentrations of phosphates have on the different calcium fractions and determine the fate of the ions that are disappearing from the calcium pool. This study was done using two models of digitalis intoxication, one in the intact dog and the other in the heart-lung preparation and two protocols in which the experiments were carried out using blood in vitro. The results show: 1) the administration of phosphates into the intact dog produces a small decrease in the total calcium content of plasma and blood. 2) the increase in phosphate concentration runs parallel to an important decrease in free calcium. 3) In the heart-lung preparation, phosphate administration markedly decreases free calcium but does not lower total calcium in plasma or blood. 4) An increase in phosphate concentration of plasma in in vitro conditions does not alter total calcium and decreases free calcium in a linear relationship with the levels of phosphates. 5) A fraction of the phosphates added to the plasma and the ions that are disappearing from the free calcium pool are binding to a plasmatic macromolecule (most probably a protein) which prevents them from precipitating.


Assuntos
Antiarrítmicos/uso terapêutico , Cálcio/sangue , Fosfatos/uso terapêutico , Animais , Glicosídeos Digitálicos/intoxicação , Cães , Avaliação Pré-Clínica de Medicamentos , Radicais Livres , Técnicas In Vitro , Sódio/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA